Pages that link to "Q72765106"
The following pages link to High-dose acyclovir compared with short-course preemptive ganciclovir therapy to prevent cytomegalovirus disease in liver transplant recipients. A randomized trial (Q72765106):
Displaying 50 items.
- Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients (Q24200697) (← links)
- Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients (Q24200991) (← links)
- Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients (Q24243124) (← links)
- Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients (Q24244606) (← links)
- Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients (Q24245848) (← links)
- Clinical utility of viral load in management of cytomegalovirus infection after solid organ transplantation (Q26826856) (← links)
- Randomised comparison of ganciclovir and high-dose acyclovir for long-term cytomegalovirus prophylaxis in liver-transplant recipients (Q33488688) (← links)
- New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients (Q33812425) (← links)
- Recent advances in the therapy and prevention of CMV infections (Q33841597) (← links)
- Prophylaxis for CMV should now replace pre-emptive therapy in solid organ transplantation (Q34191785) (← links)
- Prophylaxis for CMV should not now replace pre-emptive therapy in solid organ transplantation (Q34191791) (← links)
- Prophylaxis against herpesvirus infections in transplant recipients (Q34196618) (← links)
- Infection in solid organ transplantation. (Q34294779) (← links)
- Prevention of infections in solid organ transplant recipients (Q34294796) (← links)
- Prevention and treatment of cytomegalovirus infection in organ transplant recipients (Q34294851) (← links)
- Cytomegalovirus infection in solid organ transplantation: economic implications (Q35107691) (← links)
- The human cytomegalovirus. (Q35143349) (← links)
- Infections in solid-organ transplant recipients (Q35376486) (← links)
- Cytomegalovirus infection in the liver transplant recipient. Epidemiology, pathogenesis, and clinical management (Q35962177) (← links)
- Viral prophylaxis in organ transplant patients (Q35962532) (← links)
- Quantification of cytomegalovirus DNA in peripheral blood leukocytes by a branched-DNA signal amplification assay (Q36547227) (← links)
- WITHDRAWN: Cytomegalovirus prophylaxis with antiviral agents for solid organ transplantation (Q36884962) (← links)
- Qualitative and semiquantitative polymerase chain reaction testing for cytomegalovirus DNA in serum allows prediction of CMV related disease in liver transplant recipients (Q37229975) (← links)
- Cytomegalovirus retinitis: are intraocular devices the answer? (Q39714123) (← links)
- Optimization of detection of cytomegalovirus viremia in transplantation recipients by shell vial assay. (Q40009291) (← links)
- Diagnosis of cytomegalovirus infections by shell vial assay and conventional cell culture during antiviral prophylaxis (Q40180848) (← links)
- Ganciclovir. An update of its therapeutic use in cytomegalovirus infection (Q40395491) (← links)
- Cytomegalovirus Infection in Marrow Transplantation (Q40424165) (← links)
- Fever in liver transplant recipients in the intensive care unit. (Q40628319) (← links)
- Causes of leukocytosis in liver transplant recipients: relevance in clinical practice (Q40642443) (← links)
- Management of cytomegalovirus infection after solid-organ or stem-cell transplantation. Current guidelines and future prospects (Q40869910) (← links)
- Prevention of cytomegalovirus disease (Q40923559) (← links)
- DRUG THERAPY OF CYTOMEGALOVIRUS INFECTIONS (Q41149358) (← links)
- CMV infection of transplant recipients (Q41173267) (← links)
- Prophylactic antiviral therapy in CMV high-risk liver transplant recipients (Q43553165) (← links)
- Use of combination cytomegalovirus immune globulin plus ganciclovir for prophylaxis in CMV-seronegative liver transplant recipients of a CMV-seropositive donor organ: a multicenter, open-label study. (Q43640074) (← links)
- Impact of human herpesvirus-6 on the frequency and severity of recurrent hepatitis C virus hepatitis in liver transplant recipients. (Q43967323) (← links)
- Preemptive strategy for ganciclovir administration against cytomegalovirus in liver transplantation recipients (Q44249073) (← links)
- Cost-effectiveness of different strategies of cytomegalovirus prophylaxis in orthotopic liver transplant recipients (Q44411929) (← links)
- Efficacy preemptive therapy with ganciclovir for the prevention of cytomegalovirus disease in liver transplant recipients (Q44735264) (← links)
- Prevention of cytomegalovirus disease in transplant recipients (Q44903852) (← links)
- Does valganciclovir hydrochloride (valcyte) provide effective prophylaxis against cytomegalovirus infection in liver transplant recipients? (Q46742608) (← links)
- Persistent lack of human herpesvirus-6 specific T-helper cell response in liver transplant recipients (Q52010634) (← links)
- Summary of the II International Symposium on Cytomegalovirus. (Q53350069) (← links)
- Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. The Oral Ganciclovir International Transplantation Study Group [corrected]. (Q53356778) (← links)
- [Infection after orthotopic liver transplantation: analysis of the first 120 consecutive cases]. (Q54044006) (← links)
- Oral ganciclovir usage for cytomegalovirus prophylaxis in organ transplant recipients: is emergence of resistance imminent? (Q54132682) (← links)
- Preemptive treatment approach to cytomegalovirus (CMV) infection in solid organ transplant patients: relationship between compliance with the guidelines and prevention of CMV morbidity (Q60211208) (← links)
- Comparison of a new quantitative cytomegalovirus DNA assay with other detection methods (Q73483214) (← links)
- Prophylaxis of cytomegalovirus infection in liver transplantation: a randomized trial comparing a combination of ganciclovir and acyclovir to acyclovir. NIDDK Liver Transplantation Database (Q73536007) (← links)